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Background: Peripheral arterial occlusive disease (PAOD), which is common in male gender and elderly
population, is related with increased cardiovascular mortality and morbidity. Neutrophil to lymphocyte
ratio (NLR) has been found to be an independent predictor of cardiovascular mortality in atherosclerosis.
The aimof the present studywas to investigate the association betweenNLR and cardiovascularmortality
both in patients with intermittent claudication and critical limb ischemia.
Methods: In a retrospective study, 593 consecutive patients who had been admitted to the inpatient
ward of the vascular department of a large tertiary training and research hospital with diagnosis of
symptomatic PAOD between May 2009 and September 2012 were included. Patients were divided into
two groups according to their NLR as follows: high NLR (NLR>3.0) and low NLR (NLR≤3.0) groups.
Results: During the course of the present study [median follow-up period of 20 months (interquartile
range, 12–27)], 75 deaths occurred out of 508 patients (14.8%). Cardiovascular mortality was found to
be signiﬁcantly higher in elevated NLR group (n=43) as compared to low NLR group (n=32) (23.6% vs
9.8%, respectively; p<0.001). Even after adjustment of various risk factors, NLR>3 and age were found as
independent predictors of long-term cardiovascular mortality in Cox regression analysis [hazard ratios
(95% conﬁdence interval), 2.04 (1.26–3.30) and 1.04 (1.01–1.07), p=0.004 and p=0.004, respectively].
Conclusion: We demonstrated that an increased NLR was related with higher cardiovascular mortality in
patients with PAOD, who were admitted with critical limb ischemia or intermittent claudication. NLR,
which reﬂects the patient’s inﬂammatory status, is an inexpensive and readily available biomarker that
provides an additional level of risk stratiﬁcation beyond that provided by conventional risk scores in
predicting long-term cardiovascular mortality in PAOD.
© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.ntroduction
Peripheral arterial occlusive disease (PAOD), which is common
n male gender and elderly population, is related with increased
ardiovascular mortality and morbidity [1]. Because of the eco-
omic, social, andhealthburden impact, early andprecisedetection
∗ Corresponding author at: Mehmet Akif Ersoy Thoracic and Cardiovascu-
ar Surgery Training and Research Hospital, Department of Cardiology, 34098,
ucukcekmece, Istanbul, Turkey. Tel.: +90 5333286329; fax: +90 212 5295548.
E-mail address: altugcakmak@hotmail.com (H.A. Cakmak).
ttp://dx.doi.org/10.1016/j.jjcc.2014.02.019
914-5087/© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reof PAOD is crucial for both general and high-risk populations
[2]. Many observational studies have presented a white blood
cell (WBC) count as a predictor of coronary artery disease (acute
myocardial infarction), stroke, and cardiovascular mortality and
morbidity that is independently related with several coronary risk
factors [3–6].
Leukocytes, which are of monocyte–macrophage lineage, play
an important role in development of atherosclerosis and its com-
plications by mediating several biochemical pathways such as
arachidonic acid metabolites and platelet aggregating factors. Also,
increased WBC count can be used to stratify the patients into
risk categories for future major cardiovascular events after acute
served.
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Continuous data are presented as themedian and the interquar-
tile range (IQR, range from the 25th to the 75th percentile). Discrete
data were given as counts and percentages. The chi-square test
was used to compare for categorical variables and Mann–Whitney72 M. Erturk et al. / Journal o
yocardial infarction [7,8]. Neutrophil to lymphocyte ratio (NLR)
s an inexpensive and readily available indicator, which reﬂects the
everity and extension of systemic inﬂammation and atheroscle-
osis [9]. NLR has been found to be an independent predictor of
hort-term mortality in patients with acute coronary syndrome
10–12]. Also, the relation of elevated NLR with higher mortality
nd morbidity in patients with severe PAOD including critical limb
schemia has been shown in recent studies [13]. The strong inde-
endent predictive effect of high NLR on survival was reported in
atients undergoing high-risk vascular surgery such as abdomi-
al aortic aneursym repair, lower limb revascularization, coronary
rtery bypass graft, and carotid endarterectomy in a large observa-
ional study [14].
Although the relation between NLR and cardiovascular mortal-
tyhadbeen shown in critical limb ischemia, there is no information
bout this association in patients with intermittent claudication in
he literature. The aim of the present study was to investigate the
elation betweenNLR and cardiovascularmortality both in patients
ith intermittent claudication and critical limb ischemia.
aterials and methods
tudy design and patient selection
In this retrospective study, 593 consecutive patients who had
een admitted to an inpatient ward of the vascular department
f a large tertiary training and research hospital with diagnosis
f symptomatic PAOD between May 2009 and September 2012
ere included. The PAOD deﬁned as >50% stenosis in the symp-
omatic lower limb, which was assessed by means of clinical
valuation and conﬁrmed by lower limb angiography performed
ccording to current state of the art protocols. Symptomatic PAOD
as also deﬁned as intermittent claudication at rest and critical
imb ischemia, which included rest pain, ulceration, and gangrene
15]. Fontaine classiﬁcationwas applied for categorization of PAOD.
atients were divided into two groups according to their NLR
s follows: high NLR (NLR>3.0) and low NLR (NLR≤3.0) groups.
atients with a history of surgical lower limb amputation as a
onsequence of PAOD, previous surgical or endovascular lower
imb revascularization, history of autoimmune disease, acute infec-
ions unrelated PAOD, recent (<3 months) coronary or peripheral
evascularization, recent (<3 months) acute coronary syndrome
r stroke, decompensated heart failure, malignancy, hepatic or
enal disease, chronic inﬂammatory disease, and leukocyte count
bove reference limits (≥12×109/L) were excluded from the
tudy.
Demographic information, cardiovascular risk factors, and
omorbidities (age, smoking habits, hyperlipidemia, body mass
ndex, hypertension, diabetes mellitus, coronary artery disease,
istory of myocardial infarction or stroke, and current medica-
ion), physical examination and interventional (vascular surgery,
ngioplasty, stenting) data were recorded by systematic review of
atient hospital ﬁles. Also, the results of complete series of rou-
ine laboratory investigations including complete blood cell count
nd levels of 12h overnight fasting low-density lipoprotein (LDL),
igh-density lipoprotein (HDL), total cholesterol, and triglyceride
ere recorded. On admission, venous blood sampleswere obtained
rom all the patients andWBC, neutrophils, and lymphocyte counts
ere measured as part of the automated complete blood count
sing a Coulter LH 780 Hematology Analyzer (Beckman Coulter
reland, Inc., Mervue, Galway, Ireland). NLR was calculated as the
atio of the neutrophils and lymphocytes both obtained from the
ame automated blood sample at admission in the present study.
Firstly, the studypopulationwasdivided into threegroupsbased
n their admission NLR in order to determine the association ofology 64 (2014) 371–376
NLR on mortality and morbidity in patients with PAOD as follows:
high (NLR>3.0), intermediate (NLR 2.0–3.0), and low (NLR<2.0)
(Fig. 1). Because of the insigniﬁcant relation between mid and low
NLR groups in terms of cardiovascular mortality in Kaplan Meier
survival plot, both the intermediate and lowNLR groupswere com-
bined. The ﬁnal patient categories were presented as follows: high
NLR group (NLR>3.0) and low NLR group (NLR≤3.0).
Deﬁnitions
Smokers included current and former smokers. Hypertension
was diagnosed if systolic arterial pressure exceeded 140mmHg
and/or diastolic arterial pressure exceeded 90mmHg, or if the
patient used antihypertensive drugs. Diabetes mellitus (DM)
was diagnosed if plasma fasting glucose exceeded 126mg/dL or
if the patient used hypoglycemic agents. Hyperlipidemia was
deﬁned as fasting total serum cholesterol > 200mg/dL, LDL choles-
terol > 130mg/dL, or serum triglycerides >180mg/dL, or if the
patient used lipid-lowering drugs because of a history of hyper-
cholesterolemia [16]. Renal failure was deﬁned as a glomerular
ﬁltration rate <60mL/min per 1.73m2, which was estimated by the
simpliﬁed modiﬁcation of diet in renal disease equation [17].
Study endpoints
Follow-up data were obtained from hospital records or by
telephone interview with patients, their relatives, or their fam-
ily physicians. The clinical end point of the present study was
cardiovascular mortality. Cardiovascular death was deﬁned as
unexplained sudden death, death due to myocardial infarction,
decompensated heart failure, or hemodynamically signiﬁcant
arrhythmia.
The study was approved by the local review board and ethics
committee, and all patients gave their written informed consent.
Statistical analysisFig. 1. Kaplan–Meier curve for long-term survival according to neutrophil to lym-
phocyte ratio (NLR) groups. Cumulative event-free survival deﬁned as freedom from
death.
f Cardiology 64 (2014) 371–376 373
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Table 2
The comparison of interventional procedures between high (NLR>3) and low
(NLR≤3) groups.
NLR≤3 (n=326) NLR>3 (n=182) p
Vascular surgery, n (%) 43 (13.2) 33 (18.1)
Angioplasty/stenting, n (%) 116 (35.6) 51(28) 0.129
Conservative/palliative, n (%) 167 (51.2) 98 (53.8)
T
B
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test for continuous variables. The Spearman correlation coef-
cient was calculated for the comparison of two data sets. A
ackward stepwise multivariate logistic regression analysis that
ncluded variables with p<0.1 was performed to identify inde-
endent predictors of cardiovascular mortality. Survival analysis
as conductedusingKaplan–Meier survival curves, anddifferences
ere compared using the log-rank test. A p-value <0.05 was con-
idered statistically signiﬁcant. Analysis was performed using SPSS
ersion 17.0.0 (SPSS Inc., Chicago, IL, USA).
esults
We studied 508 out of 593 patients who presented with symp-
omatic PAOD during the study period. Eighty-ﬁve patients (15%)
ad to be excluded due to missing or lacking data about differ-
ntial WBC count or follow-up results. Therefore, the ﬁnal study
opulation consisted of 508 [median age: 64 years (IQR, 57–71),
1.3% male] patients. There were 182 patients in the high NLR
roup (NLR>3.0) and326patients in the lowNLRgroup (NLR≤3.0).
aseline demographic and clinical characteristics of the patients
ccording to NLR groups are summarized in Table 1. The high NLR
roup was older [median age 68 (IQR, 61–74) years vs median age
2 (IQR, 55–69) years, p<0.001] and tended to have a higher fre-
uency of critical limb ischemia (p=0.019) than the lowNLR group.
owever, the incidence of renal failure and intermittent claudica-
ion was higher in the low NLR group compared to the high NLR
roup (p=0.012 and p=0.019, respectively). Bodymass index,male
ender, the rate of diabetesmellitus, hypertension, hyperlipidemia,
moking, coronary artery disease, previous myocardial infarction,
revious stroke, and use of medication were not statistically dif-
erent between the two groups. Furthermore, the distribution of
atients according to the severity of critical limb ischemia was
s follows: rest pain (Fontaine stage 3, Rutherford stage 4) 61%;
schemic ulceration (Fontaine stage 4, Rutherford stage 5) 29.2%;
nd gangrene (Fontaine stage 4, Rutherford stage 6) 8.8%.
BC counts
Themedian total leukocyte countwas 8.5×109/L (IQR, 7.3–9.9),
onsisting of median counts of 5.3×109/L for neutrophils (IQR,
.4–6.6), 2.1×109/L for lymphocytes (IQR, 1.6–2.6), 0.5×109/L
or monocytes (IQR, 0.4–0.6), 0.22×109/L for eosinophils (IQR,
.13–0.32), and 0.04×109/L for basophils (IQR, 0.02–0.06). Base-
ine leukocyte and neutrophil values were higher in the high NLR
able 1
aseline demographic and clinical characteristics of the patients according to NLR groups
Variable NLR≤3 (n=326)
Age, years (median, IQR) 62 (55–69)
Body mass index, kg/m2, (median, IQR) 27.4 (25.0–29.7)
Male gender, n (%) 264 (81)
Diabetes mellitus, n (%) 127 (39)
Hypertension, n (%) 194 (59.5)
Hypercholesterolemia, n (%) 209864.1)
Smokers, n (%) 161 (49.4)
Renal failure, n (%) 60 (18.5)
Coronary artery disease, n (%) 125 (38.5)
Previous myocardial infarction, n (%) 46 (14.1)
Previous stroke, n (%) 11 (3.4)
Symptoms, n (%)
Intermittent claudication 264 (81)
Critical limb ischemia 62 (19)
Medications, n (%)
Acetylsalicylic acid 249 (76.4)
Clopidogrel 95 (29.1)
Statin 123 (37.7)
QR, interquartile range; NLR, neutrophil to lymphocyte ratio.NLR, neutrophil to lymphocyte ratio.
group [median 9.3 (IQR, 7.6–10.5)×109/L vs median 8.2 (IQR,
7.0–9.4)×109/L, p<0.001; median 6.7 (IQR, 5.3–7.7)×109/L vs
median 4.8 (IQR, 4.1–5.7)×109/L, p<0.001, respectively] than in
the low NLR group. However, baseline lymphocyte values were
lower in the high NLR group [median 1.6 (IQR, 1.2–1.9)×109/L vs
median 2.4 (IQR, 2.0–2.9)×109/L, p<0.001]. NLR showed poor but
signiﬁcant correlation with the Fontaine stage of PAOD (r=0.119,
p=0.007).
The comparison of interventional procedures between high
(NLR>3) and low (NLR≤3) groups is presented in Table 2.
There was no signiﬁcant difference between the two groups in
terms of incidence of procedures such as vascular surgery, angio-
plasty/stenting, and conservative management (p=0.129).
During the courseof thepresent study [median follow-upperiod
of 20 months (IQR, 12–27)], 75 deaths occurred out of 508 patients
(14.8%). The distribution of causes of cardiovascularmortalitywere
as follows: 8 patients with unexplained sudden death, 33 patients
with myocardial infarction, 22 patients with decompensated heart
failure, 12 patients with hemodynamically signiﬁcant arrhythmia.
Cardiovascular mortality was found to be signiﬁcantly higher in
the elevated NLR group (n=43) as compared to the low NLR group
(n=32) (23.6% vs 9.8%, respectively; p<0.001). The Kaplan–Meier
survival plot for cardiovascular mortality in both groups is pre-
sented in Fig. 2. The independentpredictors for cardiovascularmor-
tality includingage, gender, hypertension, smoking status, previous
stroke history, hyperlipidemia, diabetes mellitus, coronary artery
disease, renal failure, Fontaine category, preprocedural NLR ter-
tiles, and use of statin were included in a Cox regression model and
analyzed in a stepwise fashion. NLR>3 and agewere found as inde-
pendent predictors of cardiovascular mortality after adjustment of
other risk factors such as renal failure and Fontaine category,which
had been found as signiﬁcant predictors of mortality in unadjusted
analysis [hazard ratios (95% conﬁdence interval), 2.04 (1.26–3.30)
and 1.04 (1.01–1.07), p=0.004 and p=0.004, respectively; Table 3].
.
NLR>3 (n=182) p
68 (61–74) <0.001
27.6 (24.2–30.1) 0.629
149 (81.9) 0.806
86 (47.3) 0.069
117 (64.3) 0.289
108 (59.3) 0.287
105 (57.7) 0.072
50 (28.1) 0.012
82 (45.1) 0.140
35 (19.2) 0.131
7 (3.8) 0.783
131 (72) 0.019
51 (28)
143 (78.6) 0.573
44 (24.2) 0.229
60 (33) 0.284
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Wig. 2. Kaplan–Meier curve for long-term survival according to neutrophil to lym-
hocyte ratiowithacut-off of3.0. Cumulativeevent-free survivaldeﬁnedas freedom
rom death.
iscussion
The main ﬁndings of the present study were as follows: (1)
atients in the high NLR group were older and had higher preva-
ence of critical limb ischemia than the low NLR group; (2) NLR
howed signiﬁcant correlationwith the severity of PAODdeﬁned as
ontaine stage; (3) high NLR was associated with an increased car-
iovascular mortality; (4) age and high NLR were the independent
redictors of long-term cardiovascular mortality after adjustment
or potential confounders.
Leukocytes play an important role in active inﬂammatory pro-
esses, which may be either acute or chronic or adaptive or
aladaptive, resulting in acute coronary syndrome or PAOD. The
ossible mechanisms which may lead to atherosclerosis includ-
ng PAOD include increased inﬂammation, endothelial dysfunction,
xidative vascular damage,microvessel plugging, and hypercoagu-
ability [18]. Also, increased levels of inﬂammatory molecules such
s soluble form of adhesion molecules, monocyte chemoattrac-
ant protein-1, andmyeloperoxidase trigger inﬂammation in PAOD
19,20].
NLR has been found as a novel potential indicator which deter-
ines individuals at risk for future cardiovascular events in recent
tudies [21]. A high NLR value (NLR>3) was presented as an
able 3
ox regression analysis for predictors of cardiovascular mortality.
Unadjusted
Odds ratio (95% CI)
Age 1.06 (1.03–1.09)
Sex 1.48 (0.76–2.89)
Hypertension 1.34 (0.83–2.16)
Smoking status 1.40 (0.88–2.22)
Previous stroke 2.33 (0.32–16.81)
Hypercholesterolemia 0.83 (0.53–1.32)
Diabetes mellitus 1.26 (0.80–1.98)
Coronary artery disease 1.01 (0.64–1.61)
Renal failure 1.80 (1.10–2.92)
Fontaine category 1.75 (1.08–2.85)
NLR>3 2.70 (1.71–4.27)
WBC count 1.10 (0.97–1.25)
Statin use 1.12 (0.70–1.78)
BC, white blood cell; NLR, neutrophil to lymphocyte ratio.ology 64 (2014) 371–376
independentpredictor for severity andprognosis of coronary artery
disease in patients undergoing coronary angiography [22]. Ergelen
et al. [10] showed that high NLR value (NLR>6.97) was associated
with increased in-hospital and long-term cardiovascular mortality
in patients undergoing primary angioplasty procedures. Moreover,
NLR was reported as a strong independent predictor of clinical
outcomes including long-term cardiovascular mortality and mor-
bidity after coronary artery bypass grafting [23] andmajor vascular
surgery [24]. The underlying pathophysiology of PAOD is thought
to be the mediation of active inﬂammatory response with neu-
trophils by numerous biochemical pathways such as releasing
of arachidonic acid metabolites and platelet-aggregating factors,
cytotoxic oxygen-derived free radicals, and hydrolytic enzymes
suchasmyeloperoxidase, elastase, varioushydrolytic enzymes, and
acid phosphatases. This low-grade and general systemic inﬂamma-
tory response leads to neutrophilia and the relative lymphopenia
of cortisol-induced stress response [25]. Also, Spark et al. [13]
reported a relation between high NLR (NLR>5.25) and increased
cardiovascular mortality in critical limb ischemia. This study was
the ﬁrst to show an independent predictive role of high NLR
for cardiovascular mortality in both critical limb ischemia and
intermittent claudication. In a prospective study of 126 patients
with PAOD, who underwent elective or emergency infrainguinal
bypass for lower limb revascularization, elevated post-operative
NLR was found to be an independent predictor for medium-term
graft patency [24]. The prediction of graft failure caused by severe
post-operative systemic inﬂammation had been presented with
this study. Furthermore, the discriminative effect of high NLR
(NLR>3.95) forpatients athigh risk regarding critical limb ischemia
in PAOD was reported in a recent study [26]. In our study, criti-
cal limb ischemia was signiﬁcantly more prevalent in the group
with >NLR 3.0. The signiﬁcant relation of high NLR with worsen-
ing renal function in type 2 diabetes mellitus was also reported
by Azab et al. [27]. The prevalence of chronic renal failure was
higher in the high NLR group as compared to the low NLR group
in our study. Also similar to previous studies, ages of the patients
in the high NLR group were found to be signiﬁcantly higher as
compared the low NLR group in the present study. However, the
relationbetween increasedNLRand long-termcardiovascularmor-
tality remained signiﬁcant even after adjustment for the factor of
age.
NLR has emerged as an important novel biomarker which sin-
gles out individuals at risk for future major cardiovascular events
[28,29]. There are many studies comparing the predictive value of
NLR and total WBC count in the literature. Arbel et al. [22] reported
the NLR as a better predictor of cardiovascular events when com-
pared to the WBC count or neutrophil count even after controlling
for various well known risk factors in patients with coronary artery
Adjusted
p Odds ratio (95% CI) p
<0.001 1.04 (1.01–1.07) 0.004
0.246
0.236
0.156
0.400
0.439
0.321
0.954
0.019 1.21 (0.72–2.03) 0.467
0.023 1.56 (0.95–2.55) 0.080
<0.001 2.04 (1.26–3.30) 0.004
0.156
0.641
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isease undergoing coronary angiography. The NLR, the combina-
ion of elevated neutrophils and low levels of lymphocytes into
single composite marker of inﬂammation, could provide addi-
ive information to stratify patients with coronary artery disease
or future cardiovascular events than the total WBC count. NLR
evealed information that was not evident from the total leukocyte
ount in this study [22]. Horne et al. [9] reported theNLR as an inde-
endent predictor of death and myocardial infarction in patients
ith coronary artery disease, outweighing the predictive ability
rovided by total WBC count and neutrophil count in their large
ohort studies. They also found NLR to have incremental predictive
alue over total WBC count in predicting postdischarge mortality.
imilar results were presented by Nún˜ez et al. [30] in patients with
T segment elevation myocardial infarction. The overall discrim-
natory ability of maximum NLR was found to be superior when
ompared with maximum WBC count. The NLR provided raised
rognostic information beyondWBC count.Moreover, Suliman and
amhane et al. [31,25] showed that a simple, relatively inexpen-
ive and universally available test (WBC count with differential)
ontains signiﬁcant risk stratiﬁcation information with a greater
redictive ability with NLR rather than the total WBC count in
cute coronary syndrome. Elevated NLR, as an independent predic-
or, combines the predictive risk of neutrophils and lymphocytes
nto a single risk factor. It conveys crucial information about com-
lex and severe inﬂammatory activity in the heart and vascular
ystem especially during acute phases of various diseases. Fur-
hermore, Bhutta et al. investigated the predictive role of NLR for
edium-term survival following elective major vascular surgery.
he NLR but not WBC count independently predicted event-free
urvival in patients undergoing high-risk vascular surgery at the
nd of their study [14]. Similar to this study, Haumer et al. [32]
id not ﬁnd any signiﬁcant association between total WBC count
nd cardiovascular outcome in patients with peripheral artery dis-
ase. In our study, leukocyte counts did not predict the long-term
urvival in univariate analysis in patients with PAOD whereas NLR
id.
The association of neutrophil count with the severity of PAOD
eﬁned as Fontaine stage was investigated [32]. Haumer et al. [32]
id not ﬁnd any signiﬁcant relation between neutrophil count and
ontaine stage in patients with intermittent claudication or criti-
al limb ischemia. In contrast to this study, the signiﬁcant relation
etween NLR and Fontaine stage in PAOD was demonstrated ﬁrstly
n our study.
Kaplan–Meier analysis showed that many events occurred after
everal months of admission in the high NLR group. These ﬁnd-
ngs were similar to some previous studies which had been done
or various diseases [13,22,28,29,25]. NLR reﬂects the balance
f the neutrophilia of inﬂammation and the relative lymphope-
ia of cortisol-induced stress response. The chronic and severe
nﬂammation affecting NLR [delayed apoptosis of neutrophils and
ymphocytes, chronic neutrophilia which could mark an increased
hronic adaptive response to ischemia, chronic physiological stress
eading to raised cortisol production resulting in lymphopenia,
defective clearance of apoptotic cells from poor phagocytosis
f apoptotic cells results in a secondary necrosis inducing secre-
ion of proinﬂammatory cytokines (tumor necrosis factor- and
nterleukin-6)] may lead to delayed cardiac events after onset of
ymptoms.Moreover, application ofmodernmedical and interven-
ional therapies for PAOD may decrease the progression of vascular
omplications in high-risk patients [13,22,28,29,25].
The main limitation of the present study was the retrospective
esign. Because of single measurement on admission, the changes
n NLR in response to treatment could not be evaluated. The lack
f measurement of ankle brachial index and inﬂammatory mark-
rs such as C-reactive protein (CRP) was another limitation of our
tudy.Moreover, the lack of assessment of correlation betweenNLR
[ology 64 (2014) 371–376 375
and other inﬂammatorymarkers such as CRP in patientswith PAOD
was the last limitation of this study.
Conclusion
Wedemonstrated that an increasedNLRwas relatedwithhigher
cardiovascular mortality in patients with PAOD, who were admit-
ted for critical limb ischemia or intermittent claudication. Even
after adjustment of various risk factors, age and NLR>3 were found
as independent predictors for cardiovascular mortality in patients
with PAOD. NLR, which reﬂects the patient’s inﬂammatory status,
is an inexpensive and readily available biomarker that provides
an additional level of risk stratiﬁcation beyond that provided by
conventional risk scores in predicting long-term cardiovascular
mortality in PAOD.
Conﬂict of interest
None.
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